Task: Answer the multiple-choice question.
Question: Which drug exhibits a 3.638% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCCCCCC(=O)N/N=C/c1c(O)n(C(C)CC)c(=S)[nH]c1=O
b CCc1ccc(N(CC(=O)Nc2ccccc2C(=O)N2CCCC2)S(C)(=O)=O)cc1
c COc1cc(NC(=O)c2cccnc2)ccc1NC(=O)c1ccccc1Cl
Answer: c. COc1cc(NC(=O)c2cccnc2)ccc1NC(=O)c1ccccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(NC(=O)c2cccnc2)ccc1NC(=O)c1ccccc1Cl
COc1cc(NC(=O)c2cccnc2)ccc1NC(=O)c1ccccc1Cl
N-[4-[(2-chlorobenzoyl)amino]-3-methoxyphenyl]pyridine-3-carboxamide